Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma

PURPOSE: TP53 mutation, one of the most frequent mutations in early‐stage lung adenocarcinoma (LUAD), triggers a series of alterations in the immune landscape, progression, and clinical outcome of early‐stage LUAD. Our study was designed to unravel the effects of TP53 mutation on the immunophenotype...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chengde, Rao, Xiang, Lin, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897963/
https://www.ncbi.nlm.nih.gov/pubmed/33314730
http://dx.doi.org/10.1002/cam4.3655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897963/
https://www.ncbi.nlm.nih.gov/pubmed/33314730
http://dx.doi.org/10.1002/cam4.3655

Ejemplares similares